As of March 2024 Quest Diagnostics has a market cap of $14.73 Billion. This makes Quest Diagnostics the world's 1220th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $14.73 B | -4.94% |
2023 | $15.50 B | -12.99% |
2022 | $17.81 B | -16.05% |
2021 | $21.22 B | 32.15% |
2020 | $16.06 B | 13.07% |
2019 | $14.20 B | 26.35% |
2018 | $11.24 B | -16.26% |
2017 | $13.42 B | 5.36% |
2016 | $12.74 B | 25.24% |
2015 | $10.17 B | 5.35% |
2014 | $9.65 B | 25.25% |
2013 | $7.70 B | -16.43% |
2012 | $9.22 B | 0.73% |
2011 | $9.15 B | -0.59% |
2010 | $9.21 B | -16.75% |
2009 | $11.06 B | 8.99% |
2008 | $10.15 B | -1.13% |
2007 | $10.27 B | -0.09% |
2006 | $10.27 B | 0.62% |
2005 | $10.21 B | 5.66% |
2004 | $9.66 B | 28.64% |
2003 | $7.51 B | 34.85% |
2002 | $5.57 B | -19.05% |
2001 | $6.88 B |
On Mar 28th, 2024 the market cap of Quest Diagnostics was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
LabCorp LH | $18.37 B | 24.68% | ๐บ๐ธ USA |
Translate Bio
TBIO.defunct | $2.82 B | -80.84% | ๐บ๐ธ USA |
Psychemedics PMD | $16.99 M | -99.88% | ๐บ๐ธ USA |
NeoGenomics
NEO | $2.00 B | -86.39% | ๐บ๐ธ USA |
Qiagen QGEN | $9.51 B | -35.42% | ๐ณ๐ฑ Netherlands |
Enzo Biochem ENZ | $65.05 M | -99.56% | ๐บ๐ธ USA |